Product Information
APREPITANT 40 MG CAPSULE is a generic product labeled by BluePoint Laboratories, priced at $39.7598 per EA under NDC 68001066601. Its NADAC has been published 21 times since Feb 4, 2026.
Strength
40 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001066601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA207777On Market Since
12/1/2025
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 40 MG CAPSULE has been published 21 times since Feb 4, 2026, and over the history we have for it it has declined 15.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.7598 per EA |
|---|---|
| All-time high | $47.0160 (Feb 11, 2026) |
| All-time low | $38.1856 (May 20, 2026) |
| 52-week high | $47.0160 |
| 52-week low | $38.1856 |
| Median price | $42.4485 |
| Average price | $42.3076 |
| Largest weekly change | -9.3% (Mar 18, 2026) |
| Weeks tracked | 21 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APREPITANT 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 40 MG CAPSULE, manufactured by BluePoint Laboratories, is $39.7598 per EA (NDC 68001066601), effective Jun 24, 2026.
How has the price of APREPITANT 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 40 MG CAPSULE has declined 15.4%. It has been tracked across 21 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for APREPITANT 40 MG CAPSULE?
Since Feb 4, 2026, the NADAC for APREPITANT 40 MG CAPSULE has ranged from a low of $38.1856 (May 20, 2026) to a high of $47.0160 (Feb 11, 2026), with a median of $42.4485 per EA.
Are there cheaper alternatives to APREPITANT 40 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as APREPITANT 40 MG CAPSULE, but none are currently priced below it.
Who manufactures APREPITANT 40 MG CAPSULE?
APREPITANT 40 MG CAPSULE (NDC 68001066601) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification